Cargando…
A methylation‐based mRNA signature predicts survival in patients with gastric cancer
BACKGROUND: Evidence suggests that altered DNA methylation plays a causative role in the occurrence, progression and prognosis of gastric cancer (GC). Thus, methylated-differentially expressed genes (MDEGs) could potentially serve as biomarkers and therapeutic targets in GC. METHODS: Four genomics p...
Autores principales: | Li, Yang, Sun, Rongrong, Zhang, Youwei, Yuan, Yuan, Miao, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336496/ https://www.ncbi.nlm.nih.gov/pubmed/32647495 http://dx.doi.org/10.1186/s12935-020-01374-w |
Ejemplares similares
-
Joint analysis of lncRNA m(6)A methylome and lncRNA/mRNA expression profiles in gastric cancer
por: Lv, Zhi, et al.
Publicado: (2020) -
A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020) -
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
por: Zhang, Chen, et al.
Publicado: (2020) -
Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
por: Chen, Jing, et al.
Publicado: (2020) -
Identification of circRNA–miRNA–mRNA regulatory network in gastric cancer by analysis of microarray data
por: Guan, Yong-jun, et al.
Publicado: (2019)